F. De Baets (Gent, Belgium)
Lack of NOS2 expression in CF epithelial cells in response to stimulation
E. N. Sutanto, A. Kicic, A. Fonceca, D. A. Knight, S. M. Stick (Nedlands, Subiaco, Australia; Vancouver, Canada)
|  |
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
C. M. Robroeks, P. P. Rosias, D. van Vliet, K. D. van de Kant, R. Jöbsis, H. J. Hendriks, J. B. L. Yntema, H. J. Brackel, R. van Gent, E. Dompeling (Maastricht, Sittard, Nijmegen, Eindhoven, Veldhoven, Netherlands)
| |
Proteomics based investigations of burkholderia cepacia complex species
C. Aldridge, A. De Soyza, C. M. A. Khan, P. A. Corris (Newcastle, United Kingdom)
| |
Assessment of structural airway abnormalities using automated CT-analysis of bronchial lumen diameter and wall thickness in patients with cystic fibrosis
M. Eichinger, O. Weinheimer, M. Puderbach, J. Gahr, S. Ley, F. M. Mueller, C. P. Heussel, H. U. Kauczor (Heidelberg, Mainz, Germany)
| |
Automated CT-analysis of bronchial lumen diameter and wall thickness in patients with cystic fibrosis
M. Eichinger, O. Weinheimer, M. Puderbach, J. Gahr, S. Ley, F. M. Mueller, C. P. Heussel, H. U. Kauczor (Heidelberg, Mainz, Germany)
| |
Chronic use of azithromycin in CF is associated with a substantial increase in macrolide resistance of S. aureus and haemophilus
H. A. Tiddens, S. J. Phaff, H. A. Verbrugh, A. Ott (Rotterdam, Netherlands)
|  |
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
L. J. van der Giessen, J. C. de Jongste, R. Gosselink, W. C. J. Hop, H. A. W. M. Tiddens (Rotterdam, Netherlands; Leuven, Belgium)
| |
Inhaled bronchodilators in cystic fibrosis: a Cochrane review
C. P. Halfhide, J. M. Couriel (Liverpool, United Kingdom)
| |